Objective. The spondyloarthritides (SpA) are a group of rheumatic diseases characterized by ossification and inflammation of entheseal tissue, the region where tendon attaches to bone. Interleukin-23 (IL-23) is involved in the pathogenesis of SpA by acting on IL-23 receptor (IL-23R) expressed on enthesis-resident lymphocytes. Upon IL-23 binding, CD31CD42CD82 tissueresident lymphocytes secrete IL-17A and IL-22, leading to inflammation, bone loss, and ossification. Knowledge about enthesis-resident lymphocytes remains fragmentary, and the contribution of entheseal g/d T cells in particular is not clear. This study was undertaken to investigate the presence of g/d T cells in the enthesis.
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Objective. The spondyloarthritides (SpA) are a group of rheumatic diseases characterized by ossification and inflammation of entheseal tissue, the region where tendon attaches to bone. Interleukin-23 (IL-23) is involved in the pathogenesis of SpA by acting on IL-23 receptor (IL-23R) expressed on enthesis-resident lymphocytes. Upon IL-23 binding, CD31CD42CD82 tissueresident lymphocytes secrete IL-17A and IL-22, leading to inflammation, bone loss, and ossification. Knowledge about enthesis-resident lymphocytes remains fragmentary, and the contribution of entheseal g/d T cells in particular is not clear. This study was undertaken to investigate the presence of g/d T cells in the enthesis.
Methods. We used 2-photon microscopy and flow cytometry to analyze entheseal lymphocytes from C57BL/ 6, Tcrd-H2BeGFP, Rorc-GFP, and IL-23R-eGFP mice. To analyze entheseal g/d T cells in IL-232induced inflammation, Tcrd-H2BeGFP mice were crossed with mice of the susceptible B10.RIII background. Hydrodynamic injection of IL-23 minicircle DNA was performed for overexpression of IL-23 and induction of inflammation. Light-sheet fluorescence microscopy was used to visualize arthritic inflammation.
Results. Activated Vg61CD272 g/d T cells were abundant in uninflamed entheseal tissue and constituted the large majority of retinoic acid receptor2related orphan nuclear receptor gt (RORgt)1IL-23R1 enthesisresident lymphocytes. Fetal thymus2dependent g/d T cells were the main source of IL-17A at the enthesis. Under inflammatory conditions, g/d T cells increased in number at the Achilles tendon enthesis, aortic root, and adjacent to the ciliary body.
Conclusion. Entheseal g/d T cells are derived from fetal thymus and are maintained as self-renewing tissueresident cells. As main IL-17A producers within tissues exposed to mechanical stress including enthesis, g/d T cells are key players in the pathogenesis of IL-232induced local inflammation.
The spondyloarthritides (SpA) are a group of rheumatic diseases that include reactive arthritis, psoriatic arthritis, and inflammatory bowel disease (IBD)-associated arthritis as well as ankylosing spondylitis (AS), the prototype of SpA. SpA mainly manifests as inflammation and ossification of entheseal tissue, the region where tendon fibers or ligaments attach to bone. In humans, the disease entity primarily affects the axial skeleton, leading to chronic back pain and diminished mobility, but it also comprises extraarticular manifestations (1), such as psoriasis, gut inflammation, uveitis, and aortitis (2) .
Genome-wide association studies identified a number of genes that confer susceptibility to SpA (3), including HLA-B27, endoplasmic reticulum aminopeptidase 1 (ERAP-1) and ERAP-2, and particularly interleukin-23 receptor (IL-23R). Suggesting a common pathogenic mechanism, a similar linkage to IL-23R polymorphisms was identified in psoriasis (4) and IBD (5) , which are often associated with axial arthritis and enthesitis. Within the last few years, a key role of IL-23 in the pathogenesis of SpA was suggested (6) . Data collected from HLA-B27-transgenic rats indicated possible links between HLA-B27 and the IL-23 cytokine pathway, since HLA-B27 misfolding led to increased IL-23 secretion by macrophages (7) and lamina propria mononuclear cells (8) , thereby likely conferring susceptibility to SpA. Indeed, elevated levels of IL-23 were identified in serum (9) and in intestinal biopsy samples (10) from AS patients.
Recently, using an IL-23-dependent mouse model of experimental SpA, Sherlock and colleagues demonstrated that IL-23 is specifically involved in the induction of entheseal inflammation by acting on enthesis-resident IL-23R1CD31CD42CD82 lymphocytes (11) . Upon IL-23 binding, entheseal CD31 lymphocytes secreted high amounts of IL-17 and IL-22, inducing typical features of SpA, such as enthesitis and new bone formation (11) . In fact, elevated levels of serum IL-17 (9) and IL-17-and IL-22-producing peripheral blood CD41 T cells have been observed in AS patients (12) . Notably, patients with enthesitis-related arthritis also displayed increased frequencies of synovial fluid IL-17 (13) .
To date, only a few analyses of entheseal inflammatory infiltrates from SpA patients have been performed. So far, accumulations of either CD31 T cell (14) , macrophage (15) , or mast cell (16) have been described. In this study, we further characterized the elusive enthesisresident CD42CD82 T cell population that was first identified in mice by Sherlock and colleagues (11) . In contrast to the majority of a/b T cells, g/d T cells are not major histocompatibility complex2restricted and lack surface expression of the co-receptors CD4 and CD8. They are scarce in secondary lymphoid organs, but represent a main lymphocyte population within epithelial or mucosal tissues such as skin or intestine. Therefore, in this study we hypothesized and investigated to what extent g/d T cells constituted the entheseal lymphocyte population. In humans, an enrichment of IL-172producing IL-23R1 g/d T cells was recently identified in the peripheral blood of patients with AS (17) or enthesitis-related arthritis (13) . Thus, it was likely that g/d T cells are enthesis-resident key producers of IL-17A.
Using Tcrd-H2BeGFP reporter mice, we identified and characterized a novel population of mouse enthesisresident g/d T cells that readily produce IL-17A at this specific anatomic site. We showed that in mice overexpressing IL-23, entheseal g/d T cells accumulate at the Achilles tendon enthesis, the aortic root, and the eye.
MATERIALS AND METHODS

Mice. B10.RIII-H2
r H2-T18 b /(71NS)SnJ (here B10.RIII) and C57BL/6 mice were purchased from The Jackson Laboratory.
C57BL/6-Trdc
tm1Mal
/J (here Tcrd-H2BeGFP) mice (18) encoding an internal ribosome entry site (IRES) and a human histone (H2B) fused to enhanced green fluorescent protein (EGFP) downstream of the Tcrd constant region, C57BL/6-Tg(Rorc-EGFP)1Ebe (here Rorc-GFP) mice (19) expressing EGFP under control of the Rorc locus on a bacterial artificial chromosome, and C57BL/6-Il23r tm1Kuch (here IL-23R-eGFP) mice (20) were used. As opposed to Tcrd-H2BeGFP and Rorc-GFP mice, which allow normal Tcrd and Rorc expression unaffected by the transgene, IL-23R-eGFP mice contain an IRES2EGFP cassette introduced into an exon of the IL-23r locus, causing intragenic deletion. Homozygous mice are unresponsive to signals via the IL-23R, whereas the heterozygous mice that were used in this study allow normal signaling and detection of IL-23R expression. To generate Indu-Rag1 3 Tcrd-H2BeGFP mice with lymphocyte development inducible by tamoxifen (21), Rag1 2/2 mice (22) were crossed to the Tcrd-H2BeGFP strain. Mice were injected with tamoxifen between 8 and 16 weeks of age. For induction of IL-232dependent inflammation, Tcrd-H2BeGFP mice were crossed to the B10.RIII background for 5 generations (B10.Tcrd-H2BeGFP). All animals were maintained under specific pathogen2free conditions in the Central Animal Facility at Hannover Medical School. Mice were analyzed at 6212 weeks of age. Experiments were carried out according to institutional guidelines approved by the Lower Saxony State Office for Consumer Protection and Food Safety animal care and use committee.
Antibodies. Antibodies against CD3 (145-2C11), T cell receptor b (TCRb; REA318), CD44 (IM7.8.1), and TCRg/d (GL-3) were purchased from Miltenyi Biotec. Antibodies against CD27 (LG.3A10), Ly6C (HK1.4), Vg1 (2.11), and Vg4 (UC3-10A6) were obtained from BioLegend, antibodies against CD45.2 (104), IL-17A (eBio17B7), interferon-g (IFNg; XMG1.2), and rat IgM (RM-7B4) were from eBioscience. Anti-CCR6 (140706) and anti2IL-23R (078-1208) were purchased from BD PharMingen. Antibodies against CD4, CD8, CD62L, and Vg6 (17D1) were produced from rat hybridoma cell lines. The 17D1 antibody recognizing Vg5 and Vg6 when combined with anti-TCRg/d (GL-3) has been described previously (21, 23) .
Preparation of entheseal cells for flow cytometric analysis. Entheseal cells were isolated as previously described (11) , with the following minor modifications. Tissue was digested for 2 hours in RPMI (Invitrogen) containing 10% fetal calf serum, 3 mg/ml collagenase D (Roche), and 112 mg/ml DNase (Roche). Digestion was stopped by adding 0.02M EDTA during the last 15 minutes. Dead cells were either stained with DAPI or Zombie Aqua (BioLegend). For intracellular cytokine staining, cells were incubated for 3 hours with phorbol myristate acetate (PMA) (50 ng/ml; Calbiochem), ionomycin (2 mg/ml; Invitrogen), and brefeldin A (1 mg/ml; Sigma) or overnight in the presence of IL-23 (10 ng/ml; R&D Systems) supplemented with brefeldin A (1 mg/ml; Sigma) for the last 3 hours. Cells were fixed and permeabilized with Cytofix/Cytoperm (BD Biosciences) according to the manufacturer's instructions.
IL-23 minicircle2induced inflammation. The IL232encoding vector RSV-mIL23-MN100A (MC-Easy Minicircle Production Kit) was obtained from BioCat. Using standard molecular techniques, 331 and 425 basepairs within the IL-23p19 and IL-12/IL-23p40 subunits, respectively, were excised to obtain IL-232deficient control vector DNA. Minicircle induction was performed according to the manufacturer's instructions, with minor modifications. Briefly, 10 ml Luria-Bertani (LB) medium containing 50 mg/ml kanamycin was inoculated with glycerol stock bacteria and incubated overnight at 308C with shaking. LB/ kanamycin (440 ml) was inoculated overnight with 10 ml of bacterial culture and grown until the optical density at 600 nm reached 0.3. L-arabinose was then added in a final concentration of 1%. Bacteria were further grown for up to 3 hours, and minicircle DNA was isolated. Before in vivo application of minicircle DNA vector technology, functionality of control and IL-23 minicircle DNA was analyzed in vitro (see Supplementary Methods and Supplementary Figure 1 , available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/10. 1002/art.39732/abstract). B10.Tcrd-H2BeGFP mice were hydrodynamically injected in the tail vein with 20 mg of purified minicircle DNA diluted in Ringer's solution in a final volume of 10% per body weight. In vivo transgene expression was monitored by measuring serum IL-23 protein levels using enzymelinked immunosorbent assay (ELISA), performed according to the manufacturer's instructions (Mouse IL-23 ELISA MAX Deluxe Set; BioLegend). Mice were killed 21230 days after injection.
Two-photon microscopy. For ex vivo imaging of ankle joints and spines, mice were killed and perfused. Skin and organs were removed, and the entheseal regions were dissected carefully. Joints were immobilized in a petri dish using tissue adhesive. For in vivo imaging, mice were anesthetized and mounted onto a 378C heating plate. The Achilles tendon entheses were dissected carefully to visualize entheseal g/d T cells. For in vivo imaging of skin-resident g/d T cells, a coverslip was placed on the ventral side of the ear. To analyze lymph node2resident g/d T cells, the inguinal lymph nodes were isolated and immobilized in a custom-built imaging chamber using tissue adhesive. Lymph nodes were superfused with oxygenated medium (95% O 2 /5% CO 2 ) supplemented with 1% penicillin/streptomycin. Imaging was performed with a TriM Scope (LaVision BioTec) equipped with an upright Olympus BX51 microscope with a 203/0.95 water immersion objective and a pulsed Ti sapphire infrared laser (Mai Tai; SpectraPhysics) turned to 920 nm. Fields of view of 500 mm (x) 3 500 mm (y) 3 1142186 mm (z) were acquired using a z-step size of 326 mm. Data analysis was performed using Imaris software 7.7.2 (Bitplane).
Light-sheet fluorescence microscopy. Sample preparation was adapted from the method of Ert€ urk and colleagues (24) . Mouse joints were collected, fixed in phosphate buffered saline (PBS) with 2% paraformaldehyde and 30% sucrose, and subsequently washed in PBS. Tissues were dehydrated in 50% tetrahydrofuran (THF) for 10 hours, in 75% THF overnight, and twice in 100% THF for at least 5 hours each. Samples were cleared overnight in dibenzyl ether and imaged after clearing was completed. Images were acquired using a light-sheet fluorescence microscope (Ultramicroscope II; LaVision BioTec) equipped with an sCMOS camera (Andor Neo) and a 23/0.5 objective lens (Olympus). Three-dimensional projections were analyzed with Imaris software 7.7.2 (Bitplane).
Micro2computed tomography (micro-CT). Micro-CT was performed using an Inveon micro-CT scanner (Siemens) equipped with Inveon Acquisition Workplace software 1.5 (Siemens). Data were acquired using filter 2 with a photon energy of 80 kV, a current of 500 mA, and an exposure time of 200 msec. Data reconstruction was performed using bilinear interpolation, the Shepp-Logan reconstruction filter, and the beam-hardening coefficient for standard soft tissue. Image analysis was performed using Inveon Research Workplace software 2.3 (Siemens).
Histologic analysis. Mouse organs were collected and frozen in Tissue-Tek OCT compound (Sakura) on dry ice. Eight-micrometer cryosections were cut using a cryomicrotome (CM3050; Leica), and sections were fixed with acetone. Organs were stained with either hematoxylin and eosin or anti-CD3 (17A2; made in-house) and anti-CD45 (30-F11; eBioscience). Images were acquired using a motorized upright Olympus BX61 fluorescence microscope equipped with a 103/0.4 objective (UPlanSApo; Olympus), 2 cameras (ColorView IIIu and FView II; Olympus), and cellSens software 1.12 (Olympus).
Statistical analysis. Statistical analyses were performed using GraphPad Prism software.
RESULTS
Tissue-resident g/d T cells in the enthesis. In this study, we sought to investigate the presence of g/d T cells in mouse entheseal tissues. To this end, we first performed 2-photon microscopy of the ankle joints of naive Tcrd-H2BeGFP reporter mice ( Figure 1A ). The TcrdH2BeGFP reporter mouse model enables direct identification of g/d T cells based on their intense nuclear fluorescence (18) . Ex vivo imaging of the Achilles tendon insertion into the posterior calcaneus allowed us to visualize numerous entheseal g/d T cells ( Figure 1A ). We further monitored the motility of enthesis-resident g/d T cells in TcrdH2BeGFP ankle joints ( Figure 1A ). As opposed to motile lymph node2resident or slow tissue-scanning dermal g/d T cells, but similar to dendritic epidermal g/d T cells, entheseal g/d T cells appeared to be tethered within their anatomic niches and did not exhibit migratory capacities ( Figure 1A and Supplementary Video 1, available on the Arthritis & Rheumatology web site at http://onlinelibrary. wiley.com/doi/10.1002/art.39732/abstract). Importantly, g/d T cells were also highly present in spinal entheses, specifically located where intervertebral discs attach to vertebral end plates ( Figure 1B) .
Next, entheseal lymphocytes from the ankle joints of naive Tcrd-H2BeGFP mice were isolated and compared to control lymphocytes from C57BL/6 (wild-type) mice by flow cytometry. Notably, g/d T cells represented ;25% of enthesis-resident T cells in both strains, while 75% were a/b T cells ( Figure 1C and Supplementary Figures 2A and B (19, 33) , and group 3 innate lymphoid cells (34, 35) . To visualize the presence of RORgt1 and IL-23R1 cells within entheseal tissue, we next analyzed the Achilles tendon insertion into the posterior calcaneus of Rorc-GFP and IL-23R-GFP mice using 2-photon microscopy. In naive mice, we observed several RORgt1 enthesisresident cells ( Figure 3A) , even though seemingly fewer than entheseal g/d T cells ( Figure 3A) . Consistent with the data published by Sherlock and colleagues (11) , even fewer IL-23R1 cells were located at the enthesis ( Figure 3A) .
These findings prompted us to determine the abundance of IL-17A2producing RORgt1 and IL-23R1 Figure 3C ). Approximately 50% of enthesis-resident g/d T cells were RORgt1 ( Figure 3C) , and 25% were IL-23R1 ( Figure 3C) , with a majority of those cells being Vg61 (Supplementary Figure 3) . As opposed to secondary lymphoid organs such as the spleen, where only 1.6% (32) of g/d T cells express IL-23R, but similar to the intestinal lamina propria, where 50260% of g/d T cells were shown to be RORgt1 (19) vivo stimulation with IL-23 only ( Figure 3D ). The majority of entheseal g/d T cells readily produced IL-17A after ex vivo stimulation, whereas only a minor population produced IFNg ( Figure 3D and Supplementary Figure 3) . As expected, these enthesis-resident IL-172producing g/d T cells were activated IL-23R1 cells ( Figure 3D ). Since enthesis-resident g/d T cells not only express key markers indicative of an IL-172producing phenotype, but also possess the capacity to produce IL-17A ex vivo, they most likely represent the main IL-172producing enthesis-resident lymphocyte population.
Enthesis-resident IL-172producing g/d T cells are derived from fetal thymus. Functional development of mouse g/d T cells is believed to occur in distinct waves during fetal, neonatal, and adult thymopoiesis (28) . Here, we investigated the ontogeny of enthesis-resident g/d T cells using inducible Rag1 2/2 (22) mice that were crossed to Tcrd-H2BeGFP mice (here termed Indu-Rag1 mice). These mice lack lymphocyte development until induction with tamoxifen at a defined time point (21) . Importantly, immunologic side effects are not expected after nonrecurring low-dose administration of tamoxifen. As determined by flow cytometry up to 8 weeks after induction, the proportion of g/d T cells was significantly decreased in tamoxifen-treated Indu-Rag1 mice compared to 8-week-old wild-type Tcrd-H2BeGFP mice ( Figure 4A ). Also, absolute numbers were strongly reduced in tamoxifen-treated Indu-Rag1 mice ( Figure 4A) . A severe reduction in entheseal g/d T cells in tamoxifentreated Indu-Rag1 mice was also observed by twophoton microscopy ( Figure 4B ). Using the Indu-Rag1 mouse model, Haas and colleagues previously showed that IL-172producing g/d T cells developed exclusively before birth (21) . Consistent with the findings of that study, enthesis-resident Vg61 or CCR61 g/d T cells, which are known to be IL-17 producers, were completely absent in tamoxifen-treated InduRag1 mice ( Figure 4C ). As expected, few Vg11 or Vg41 entheseal g/d T cells developed in an adult microenvironment ( Figure 4C ). Taken together, our data indicate that the development of enthesis-resident IL-172producing g/d T cells depends on an embryonic microenvironment and that these cells are later maintained as self-renewing tissue-resident cells.
Accumulation of entheseal g/d T cells at the Achilles tendon enthesis in mice overexpressing IL-23. To study entheseal g/d T cells in IL-23 minicircle2induced inflammation, we first backcrossed C57BL/6 TcrdH2BeGFP mice to the susceptible B10.RIII background. Using hydrodynamic injection, we introduced an IL232encoding minicircle DNA construct into B10.RIII mice. Overexpression of IL-23 in these mice leads to increased serum levels of IL-23, specifically inducing joint-destructive arthritis and severe bone loss (36) as well as typical features of SpA, including enthesitis and new bone formation (11) . A control group was injected with an empty control minicircle DNA construct.
Importantly, in vivo, increased serum levels of IL-23 protein, accompanied by entheseal inflammation, were detected in IL-23 minicircle2injected B10.RIII Figure 5A ). Also, significantly higher numbers of g/d T cells, specifically CD272 g/d T cells, were isolated from the entheseal tissue of IL-23 minicircle2injected mice ( Figure  5B ). The increased presence of entheseal g/d T cells was most likely due to expansion of IL-172producing Vg61, but not Vg41, g/d T cells ( Figure 5B) .
Next, we used light-sheet fluorescence microscopy of optically cleared paws as a novel read-out that allowed us to precisely visualize enthesitis with inflammatory infiltrates adjacent to interphalangeal joints ( Figure 5C and Supplementary Video 2, available on the Arthritis & Rheumatology web site at http:// onlinelibrary.wiley.com/doi/10.1002/art.39732/abstract). As monitored by micro-CT, the alterations observed by light-sheet fluorescence microscopy preceded obvious bone remodeling ( Figures 5C and D) , a hallmark of SpA (37) . Taken together, these data suggest a contribution of preactivated IL-172producing CD272IL-23R1 entheseal g/d T cells to inflammatory processes involved in enthesitis. Figure 4B) and aortic valve inflammation ( Figure 6A) , which is consistent with previous findings in mice (11) and humans (1, 2) . Notably, we observed that g/d T cells accumulated not only within the entheseal tissue in joints ( Figures 5A and B) , but also at the aortic valve and root ( Figure 6B ), further extending their enthesitis-promoting potential. In addition, SpA patients are at risk of developing uveitis (1) . In this study, mice overexpressing IL-23 displayed lymphocyte infiltrations within the uvea, with g/d T cell accumulations adjacent to the ciliary body ( Figures 6C  and D) . In summary, we demonstrated that entheseal g/d T cells are not confined to joints, but they also reside in distinct anatomic niches at the aortic valve and the uvea, where they accumulate in an IL-232dependent manner.
DISCUSSION
To date, drug treatment of SpA has been based on blockade of tumor necrosis factor (TNF) or the use of nonsteroidal antiinflammatory drugs (NSAIDs), leading to effective reduction in chronic inflammation and pain. For a long time, it was thought that these therapies were not capable of reducing and inhibiting radiographic progression, leading to entheseal new bone formation and impaired mobility (37) . Data acquired in a large longitudinal study, however, demonstrated reduced axial progression in AS patients treated with TNF inhibitors (38) . Since some patients do not respond to either TNF blockers or NSAIDs, there is still a need for alternative therapies. In recent years, several studies have identified involvement of the IL-23/IL-17 cytokine axis in the pathology of SpA (6) . The first clinical trials using anti-IL-17A antibodies for the treatment of AS, rheumatoid arthritis (RA), psoriasis, or uveitis, anti2IL-17R for the treatment of psoriatic arthritis, anti2IL-23/IL-12p40 antibodies for the treatment of AS or psoriatic arthritis, and anti2IL-23p19 antibodies for the treatment of AS (ongoing trial) have been performed, mainly yielding promising results (39) . Notably, the cellular sources of these proinflammatory cytokines remain unclear and are a subject of controversy (6) . Since data regarding human entheseal cell infiltrates are limited, the use of animal models with features of human SpA is very important to reveal pathways and cell types that might be involved in the inflammatory pathogenesis of enthesitis and ossification of entheseal tissues.
In the inflamed joints of mice with collagen-induced arthritis, a mouse model resembling human RA, g/d T cells were identified as important (40) or main (41) producers of IL-17. Vg41 IL-172producing g/d T cells were believed to exacerbate collagen-induced arthritis (40) . Recently, in an experimental mouse model of autoimmune arthritis, a population of pathogenic Vg61CCR21 IL-172producing g/d T cells was described within the joints (42) . An IL172producing g/d T cell population was also observed in mannan-induced psoriatic arthritis-like disease, causing arthritis joint inflammation as well as psoriatic lesions of the skin (43) . In contrast to our findings, both of these recently described IL-172producing g/d T cell populations were not tissue resident but immigrated from draining lymph nodes upon inflammatory stimulation. This further highlights an exceptional tissue-specific role of enthesisresident g/d T cells. In particular, the physiologic role of Vg61 IL-172producing g/d T cells in healthy animals still requires further investigation. This might include bone remodeling, adaptation, and regeneration in response to mechanical stress.
So far, only a few studies have analyzed g/d T cells in SpA patients. Two recent studies showed an enrichment of IL-172producing or even IL-23R1 IL172producing g/d T cells within the peripheral blood of patients with enthesitis-related arthritis (13) or AS (17), respectively. The presence of g/d T cells within the inflamed synovia of patients with RA or juvenile idiopathic arthritis has also been observed, although data about their pathogenic potential were a subject of controversy (44, 45) .
Entheseal organs are permanently exposed to mechanical forces and microdamage and are hence constantly switching between anabolic and catabolic processes. Thus, it is conceivable that enthesis-resident g/d T cells interfere with bone metabolism to control tissue homeostasis in rodents and humans. Jacques and colleagues identified the importance of biomechanical stress in the induction of enthesitis in mice, as hind limb unloading prevented enthesitis in generally highly susceptible TNFtransgenic mice (46) . Since tissue-resident g/d T cells within the skin or intestines are known to rapidly respond to either cytokine stimulation or stromal and epithelial cell stressinduced molecules, one could speculate that entheseal microdamage could activate enthesis-resident g/d T cells and trigger production of proinflammatory cytokines such as IL-17A. Whether genetic factors including HLA2B27 or polymorphisms in the IL-23R decrease the threshold for microdamage-induced g/d T cell activation or just alter activated g/d T cell responses remains an important open question (47) .
Given the fact that our data reveal an accumulation of g/d T cells not just in joint entheseal regions, but adjacent to the ciliary body in the eye as well as along the aortic valve and root, it appears likely that accumulation of g/d T cells in different enthesis-related tissues reveals a common IL-232driven mechanism. In humans, SpA pathologies include inflammation of gut or skin, sites which were shown in mice to contain high numbers of IL-23R1 g/d T cells (20, 48) . Using systemic administration of b-glucan to SKG mice as a suitable SpA model, the gut was demonstrated to be the main site of IL-23 production in experimental SpA (49) . Also, a relationship between host microbiota and arthritis onset and severity was reported in mice (49) . In fact, elevated IL-23 levels were found in ileal biopsy specimens from SpA patients (10) , thus proposing the gut as a key producer of excessive IL-23 in human SpA. Further, it is conceivable that the microbiome is crucially involved in the IL232dependent pathogenesis of human SpA (50) .
In conclusion, we propose that entheseal g/d T cells are key players controlling tissue homeostasis at tendon-to-bone attachment sites. The g/d T cells are the main IL-172producing cell type within the enthesisresident lymphocyte population and within the pool of RORgt1IL-23R1CD31CD42CD82 lymphocytes. We demonstrate that entheseal g/d T cells accumulate at anatomic sites that are affected during SpA, such as the Achilles tendon insertion, the aortic root, and the ciliary body.
